and Ding, S
While the overall risk appears to be small, I now screen more carefully for patients with risk factors such as pre-existing optic nerve problems, glaucoma, or significant diabetic retinopathy. Recent research also connects liraglutide, the active ingredient in Saxenda and Victoza, to similar concerns
But its a simple, non-medical intervention that can pay off in the long term and without side effects
they are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or MEN 2
Clinical evidence demonstrates that participants maintaining semaglutide treatment for one year or longer sustain weight loss of 1522% of baseline body weight, with some cohorts achieving reductions exceeding 25%
This change in particle size, along with a reduction in the total number of LDL particles, helps decrease the risk of cardiovascular events